Lupin’s Q1 results show a 16% profit growth with revenue surpassing Rs 8,200 crore, highlighting the company’s expansion in the pharmaceutical industry.
Lupin’s Q1 results show a 16% profit growth with revenue surpassing Rs 8,200 crore, highlighting the company’s expansion in the pharmaceutical industry.